Mir Conrad F 4
4 · CALMARE THERAPEUTICS Inc · Filed Mar 6, 2018
Insider Transaction Report
Form 4
Mir Conrad F
DirectorPresident, CEO and Interim CFO
Transactions
- Exercise/Conversion
Common Stock
2018-02-12$0.08/sh+1,000,000$80,000→ 1,440,751 total - Exercise/Conversion
Option
2018-02-12$0.08/sh+1,000,000$80,000→ 1,000,000 totalExercise: $0.08→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]A stock option to purchase 1,000,000 shares at an exercise price of $0.08 was granted on 10/1/2013. 20% of this option vested on 10/1/2013, 10/1/2014, 10/1/2015, 10/1/2016 and 10/1/2017, respectively.